Experimental analyses confirmed that IL20RB was significantly upregulated in CRC tissues and cell lines, and its silencing markedly inhibited CRC cell proliferation, migration, and invasion, consistent with its predicted oncogenic role. This evidence concerns the gene IL20RB and colorectal carcinoma.